Among them, E2F1, FBXO25, RANBP9, and UBXN1 were differentially expressed (p value < 0.05) in between GC tissues and normal tissues and were associated with prognosis in patients with GC (Table S7; Figure 3J). Here, E2F1 is linked to gastric cancer.